|
|
| |
|
|
|
The Global Politics of Human Embryonic Stem Cell Science
Regenerative Medicine in Transition
|
|
|
|
|
Regenerative medicine is a field characterized by a global struggle for scientific, economic and national advantage. Drawing on a wide range of interviews, primary and secondary sources, this book investigates the dynamic interactions between national regulatory formation and the global biopolitics of regenerative medicine and human embryonic stem cell science. Today governments are under intense competitive pressure to fund and develop attractive national environments for embryonic stem cell science, which promises both to improve the health and productivity of aging populations and to develop therapies for global health markets.
This study traces the development of internationally circulating arguments for and against stem cell research, and the various transnational bioethical spaces that have opened up to try and steer these arguments towards compromise and implementation. It considers the flow of embryonic and reproductive biological materials from south to north, and the ways these flows play into broader relations around global biopolitics. It investigates the place of transnational regulatory bodies like the EU and the UN in organizing and modifying the international and national debates around stem cell science, and ways in which national debates and policies influence each other. It makes a major contribution to our understanding of the dynamics of power that fuels the emergence of global regenerative medicine in the age of biotechnology.
Introduction: Stem Cell Research and Global Biopolitics
Globalization, Stem Cell Markets and National Interests
Embryos, Oöcytes, Cell Lines: HESC Science and the Human Tissue Market
Global Regulation and Local Policy Narratives: Making Sense of Dolly
From Dolly to Therapies? Stem Cell Regulations in the Making I – the United Kingdom and the United States
From Dolly to Therapies? Stem Cell Regulations in the Making II – Germany, Italy, Japan and South Korea
Bioethics and the Global Moral Economy of Human Embryonic Stem Cell Science
Human ESC Science and the Cultural Politics of the EU's Framework Programmes
Contested Governance: Uncertainty and Standardization in Research and Patenting
Notes
References
Index
HERBERT GOTTWEIS is Professor at the Department of Political Science and Director of the Life Science Governance Research Platform at the University of Vienna, Austria. His books include Biobanks: Governance in Comparative Perspective, (with A Petersen) and Governing Molecules: The Discursive Politics of Genetic Engineering in Europe and in the United States.
BRIAN SALTER is Professor of Politics and Director of the Global Biopolitics Research Group in the Centre for Biomedicine and Society at King's College London, UK. His books include The New Politics of Medicine and The Politics of Change in the Health Service.
A/PROFESSOR CATHERINE WALDBY is International Research Fellow at the University of Sydney, Australia. She researches social studies of biomedicine and the life sciences. She is a foundational member of the global biopolitics research group, an international consortium of scholars who investigate the effects of cultural, political and economic globalization on the social relations of biomedicine. Her books include (wih Robert Mitchell) Tissue Economies: Blood, Organs and Cell Lines in Late Capitalism.
Description
Regenerative medicine is a field characterized by a global struggle for scientific, economic and national advantage. Drawing on a wide range of interviews, primary and secondary sources, this book investigates the dynamic interactions between national regulatory formation and the global biopolitics of regenerative medicine and human embryonic stem cell science. Today governments are under intense competitive pressure to fund and develop attractive national environments for embryonic stem cell science, which promises both to improve the health and productivity of aging populations and to develop therapies for global health markets.
This study traces the development of internationally circulating arguments for and against stem cell research, and the various transnational bioethical spaces that have opened up to try and steer these arguments towards compromise and implementation. It considers the flow of embryonic and reproductive biological materials from south to north, and the ways these flows play into broader relations around global biopolitics. It investigates the place of transnational regulatory bodies like the EU and the UN in organizing and modifying the international and national debates around stem cell science, and ways in which national debates and policies influence each other. It makes a major contribution to our understanding of the dynamics of power that fuels the emergence of global regenerative medicine in the age of biotechnology.
Contents
Introduction: Stem Cell Research and Global Biopolitics
Globalization, Stem Cell Markets and National Interests
Embryos, Oöcytes, Cell Lines: HESC Science and the Human Tissue Market
Global Regulation and Local Policy Narratives: Making Sense of Dolly
From Dolly to Therapies? Stem Cell Regulations in the Making I – the United Kingdom and the United States
From Dolly to Therapies? Stem Cell Regulations in the Making II – Germany, Italy, Japan and South Korea
Bioethics and the Global Moral Economy of Human Embryonic Stem Cell Science
Human ESC Science and the Cultural Politics of the EU's Framework Programmes
Contested Governance: Uncertainty and Standardization in Research and Patenting
Notes
References
Index
Authors
HERBERT GOTTWEIS is Professor at the Department of Political Science and Director of the Life Science Governance Research Platform at the University of Vienna, Austria. His books include Biobanks: Governance in Comparative Perspective, (with A Petersen) and Governing Molecules: The Discursive Politics of Genetic Engineering in Europe and in the United States.
BRIAN SALTER is Professor of Politics and Director of the Global Biopolitics Research Group in the Centre for Biomedicine and Society at King's College London, UK. His books include The New Politics of Medicine and The Politics of Change in the Health Service.
A/PROFESSOR CATHERINE WALDBY is International Research Fellow at the University of Sydney, Australia. She researches social studies of biomedicine and the life sciences. She is a foundational member of the global biopolitics research group, an international consortium of scholars who investigate the effects of cultural, political and economic globalization on the social relations of biomedicine. Her books include (wih Robert Mitchell) Tissue Economies: Blood, Organs and Cell Lines in Late Capitalism.
|
|
|